Synuclein Publications
-
(2014)
Jiang, Hoekstra, Heng et al
P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation
Neurobiol. Aging; doi: 10.1016/j.neurobiolaging.2015.03.015.
-
(2014)
Andrew F. Fischer, Kathryn Mansfield Matera
Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines
Neurochemical Research; DOI: 10.1007/s11064-015-1597-y
-
(2014)
Rostovtseva, Gurnev, Protchenko et al
Alpha Synuclein Shows High-Affinity Interaction with Voltage-Dependent Anion Channel Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease
Molecular Biophysics; doi:10.1074/jbc.M115.641746.
-
(2014)
Holmqvist, Brouwer, Djelloul et al
Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors
Stem Cell Research; doi:10.1016/j.scr.2015.05.014.
-
(2014)
Ryoichi Takahashi, Kenjiro Ono, Yusaku Takamura, Mineyuki Mizuguchi, Tokuhei Ikeda, Hisao Nishijo andMasahito Yamada
Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
JNC Journal of Neurochemistry; DOI: 10.1111/jnc.13180.
-
(2013)
Scott Miners, Ruth Renfrew, Marta Swirski, Seth Love
Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1
Acta Neuropathol Commun.; doi: 10.1186/s40478-014-0164-0
-
(2013)
Heinzel S, Gold M, Deuschle C et al
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays
PLoS One; https://doi.org/10.1371/journal.pone.0114566.
-
(2013)
Pchelina, S.N., Nuzhnyib E.P., Emelyanov A.K., et al
Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases
Neuroscience Letters; doi:10.1016/j.neulet.2014.09.041.
-
(2013)
Shi, Min et al
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Acta Neurolpathol.; doi: 10.1007/s00401-014-1314-y.
-
(2013)
Kellie, J., Higgs, R., Ryder, J. et al
Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
Scientific Reports; doi:10.1038/srep05797
